Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

S Zimmermann, P Sekula, M Venhoff… - JAMA …, 2017 - jamanetwork.com
Importance Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are rare
but severe adverse reactions with high mortality. There is no evidence-based treatment, but …

SJS/TEN 2017: building multidisciplinary networks to drive science and translation

KD White, R Abe, M Ardern-Jones… - The Journal of Allergy …, 2018 - Elsevier
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a life-threatening,
immunologically mediated, and usually drug-induced disease with a high burden to …

UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016

D Creamer, SA Walsh, P Dziewulski… - British Journal of …, 2016 - academic.oup.com
JKGD has received grant/research support from Dompee and SiFi. MRA-J. has done
commissioned work for Genus Pharmaceuticals; received sponsorship from AbbVie …

Toxic epidermal necrolysis and Steven–Johnson syndrome: a comprehensive review

OA Charlton, V Harris, K Phan, E Mewton… - Advances in wound …, 2020 - liebertpub.com
Significance: Toxic epidermal necrolysis (TEN) and Steven–Johnson syndrome (SJS) are
potentially fatal acute mucocutaneous vesiculobullous disorders. Evidence to date suggests …

[HTML][HTML] Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches

C Gonzalez-Herrada, S Rodriguez-Martin… - Journal of Investigative …, 2017 - Elsevier
Several immunomodulatory agents are used in the treatment of epidermal necrolysis, but
evidence of their efficacy is limited. The Autonomous Community of Madrid has two …

[HTML][HTML] Stevens-Johnson syndrome/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States

RG Micheletti, Z Chiesa-Fuxench, MH Noe… - Journal of Investigative …, 2018 - Elsevier
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, severe
mucocutaneous reaction with few large cohorts reported. This multicenter retrospective …

[HTML][HTML] Guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis: An Indian perspective

LK Gupta, AM Martin, N Agarwal, P D'Souza… - Indian journal of …, 2016 - ijdvl.com
Background: Stevens–Johnson syndrome and toxic epidermal necrolysis are severe, life-
threatening mucocutaneous adverse drug reactions with a high morbidity and mortality that …

Retrospective analysis of StevenseJohnson syndrome and toxic epidermal necrolysis in 87 Japanese patients e Treatment and outcome

Y Yamane, S Matsukura, Y Watanabe… - Allergology …, 2016 - jstage.jst.go.jp
Background: StevenseJohnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are
rare but severe adverse drug reactions with high mortality. Methods: To present the clinical …

Evaluation of combination therapy with etanercept and systemic corticosteroids for Stevens-Johnson syndrome and toxic epidermal necrolysis: a multicenter …

J Zhang, CW Lu, CB Chen, CW Wang, WT Chen… - The Journal of Allergy …, 2022 - Elsevier
Background Stevens-Johnson syndrome–toxic epidermal necrolysis (SJS-TEN) are fatal
severe cutaneous adverse reactions, without consensus on the medical treatment. The use …

Systemic therapies for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN‐based systematic review and meta‐analysis

I Torres‐Navarro, Á Briz‐Redón… - Journal of the …, 2021 - Wiley Online Library
Background The SCORTEN score is a specific predictor of mortality for patients with Stevens–
Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). There is little evidence in …